{"title":"利用机器学习揭开中射血分数心力衰竭的神秘面纱","authors":"Achal Dixit, Soumili Chattopadhyay","doi":"10.23919/cinc53138.2021.9662749","DOIUrl":null,"url":null,"abstract":"Treating Heart Failure (HF) patients with mid-range Ejection Fraction (HFmrEF) is a challenging task due to prognostic uncertainty and transitional behaviour of HFmrEF, often referred to as “grey-area”. In this study, we address the uncertainty of HFmrEF through Machine Learning (ML) by classifying it into two well studied phenotypes: HF with preserved Ejection Fraction and HF with reduced Ejection Fraction, using the data from clinical attributes. We propose a semi-supervised Active Learning based model that uses significantly lesser data to tackle the need of supervised label validation and performs on-par with supervised ML models developed for comparison. We believe the use of proposed ML models can enable experts in making informed data-driven decisions leading to the accurate prognosis of HF patients.","PeriodicalId":126746,"journal":{"name":"2021 Computing in Cardiology (CinC)","volume":"1119 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Demystifying Heart Failure with Mid-Range Ejection Fraction Using Machine Learning\",\"authors\":\"Achal Dixit, Soumili Chattopadhyay\",\"doi\":\"10.23919/cinc53138.2021.9662749\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treating Heart Failure (HF) patients with mid-range Ejection Fraction (HFmrEF) is a challenging task due to prognostic uncertainty and transitional behaviour of HFmrEF, often referred to as “grey-area”. In this study, we address the uncertainty of HFmrEF through Machine Learning (ML) by classifying it into two well studied phenotypes: HF with preserved Ejection Fraction and HF with reduced Ejection Fraction, using the data from clinical attributes. We propose a semi-supervised Active Learning based model that uses significantly lesser data to tackle the need of supervised label validation and performs on-par with supervised ML models developed for comparison. We believe the use of proposed ML models can enable experts in making informed data-driven decisions leading to the accurate prognosis of HF patients.\",\"PeriodicalId\":126746,\"journal\":{\"name\":\"2021 Computing in Cardiology (CinC)\",\"volume\":\"1119 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2021 Computing in Cardiology (CinC)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23919/cinc53138.2021.9662749\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2021 Computing in Cardiology (CinC)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23919/cinc53138.2021.9662749","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Demystifying Heart Failure with Mid-Range Ejection Fraction Using Machine Learning
Treating Heart Failure (HF) patients with mid-range Ejection Fraction (HFmrEF) is a challenging task due to prognostic uncertainty and transitional behaviour of HFmrEF, often referred to as “grey-area”. In this study, we address the uncertainty of HFmrEF through Machine Learning (ML) by classifying it into two well studied phenotypes: HF with preserved Ejection Fraction and HF with reduced Ejection Fraction, using the data from clinical attributes. We propose a semi-supervised Active Learning based model that uses significantly lesser data to tackle the need of supervised label validation and performs on-par with supervised ML models developed for comparison. We believe the use of proposed ML models can enable experts in making informed data-driven decisions leading to the accurate prognosis of HF patients.